Tazeen Ahmad

Stock Analyst at B of A Securities

(1.51)
# 1622
Out of 5,358 analysts
238
Total ratings
41.18%
Success rate
6.17%
Average return
55 Stocks
Name Action PT Current % Upside Ratings Updated
ACAD ACADIA Pharmaceutica...
Maintains: Neutral
18 23
21.78 5.6% 14 Jun 5, 2025
ASND Ascendis Pharma
Maintains: Strong Buy
196 201
172.68 16.4% 9 Jun 3, 2025
PRTA Prothena Corp
Downgrades: Underperform
22 4
5.36 -25.37% 6 May 28, 2025
STRO Sutro Biopharma
Maintains: Underperform
1 1
0.86 -6.98% 3 May 19, 2025
DNLI Denali Therapeutics
Maintains: Buy
28 27
14.79 82.56% 3 May 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
41 23
19.45 18.25% 7 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
55 68
52.04 30.67% 15 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
63 68
67.9 0.15% 8 Apr 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
302 325
301.21 7.9% 3 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
54 28
7.49 273.83% 2 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
73 70
56.36 24.2% 5 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
42 40
4.3 830.23% 4 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
184 179
125.13 43.05% 3 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
14.21 54.82% 1 Dec 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
6 3
1.49 101.34% 3 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
68 90
68.95 30.53% 5 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 15
6.18 142.72% 5 Oct 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
11 6
6.83 -12.15% 14 Oct 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
125 150
109.09 37.5% 7 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
10 2
7.27 -72.49% 6 Sep 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
535 607
586.63 3.47% 3 Jun 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
166 213
43.41 390.67% 21 Jun 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
83 76
37.24 104.08% 6 May 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16 14
3.99 250.88% 2 Apr 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
7 10
2.71 269% 4 Mar 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
2 6
1.67 259.28% 2 Mar 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
8.93 67.97% 1 Feb 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
3
n/a n/a 2 Jan 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
7 1
n/a n/a 1 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
8 11
16.84 -34.68% 3 Dec 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
36 31
n/a n/a 2 Aug 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
10
10.9 -8.26% 6 Jul 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
7 2
3.71 -46.09% 2 Apr 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
2 7
n/a n/a 3 Feb 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
90 20
n/a n/a 2 Dec 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
6
1.04 476.92% 4 Nov 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
75 15
8.7 72.41% 3 Nov 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
390 60
45.07 33.13% 2 Jun 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
23
n/a n/a 2 May 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
16
1.35 1085.19% 1 Nov 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 2 Oct 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
24 20
n/a n/a 2 Mar 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
13 5
n/a n/a 1 Mar 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
43
10.3 317.48% 2 Sep 25, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
45 47
n/a n/a 2 Aug 3, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
6
n/a n/a 4 Apr 9, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
233 227
n/a n/a 4 Feb 26, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 3 Sep 30, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 4 Apr 25, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
330 300
9.06 3211.26% 1 Nov 2, 2018